NEET MDS Lessons
Biochemistry
Polar (Uncharged)
| Amino Acid | Key Feature |
|---|---|
| Serine (S) | Hydroxyl group |
| Threonine (T) | Hydroxyl group |
| Asparagine (N) | Amide group |
| Glutamine (Q) | Amide group |
| Tyrosine (Y) | Phenol group |
| Cysteine (C) | Thiol group |
Mnemonic: "Santa’s Team Never Quit Trying Cookies" (S, T, N, Q, T, C)
Non-Polar (Hydrophobic)
| Amino Acid | Key Feature |
|---|---|
| Glycine (G) | Smallest side chain |
| Alanine (A) | Methyl group |
| Valine (V) | Branched chain |
| Leucine (L) | Branched chain |
| Isoleucine (I) | Branched chain |
| Methionine (M) | Sulfur-containing |
| Proline (P) | Cyclic structure |
| Phenylalanine (F) | Aromatic ring |
| Tryptophan (W) | Indole ring |
Mnemonic: "Grandma Always Visits London In May For Perfect Weather" (G, A, V, L, I, M, F, P, W)
Glycogen Storage Diseases are genetic enzyme deficiencies associated with excessive glycogen accumulation within cells.
- When an enzyme defect affects mainly glycogen storage in liver, a common symptom is hypoglycemia (low blood glucose), relating to impaired mobilization of glucose for release to the blood during fasting.
- When the defect is in muscle tissue, weakness and difficulty with exercise result from inability to increase glucose entry into Glycolysis during exercise.
Various type of Glycogen storage disease are
|
Type |
Name |
Enzyme Deficient |
|
I |
Von Geirke’s Disease |
Glucose -6-phosphate |
|
II |
Pompe’s Disease |
(1, 4)glucosidase |
|
III |
Cori’s Disease |
Debranching Enzymes |
|
IV |
Andersen’s Disease |
Branching Enzymes |
|
V |
McArdle’s Disease |
Muscles Glycogen Phosphorylase |
| Enzyme | Clinical Use | Indicates |
|---|---|---|
| ALT (SGPT) | Specific to liver injury | Hepatitis, liver necrosis |
| AST (SGOT) | Found in liver, heart, muscle | Liver disease, myocardial infarction |
| ALP | Bile duct obstruction, bone disease | Cholestasis, bone metastases |
| GGT | Alcoholic liver disease, biliary obstruction | Alcohol abuse, hepatobiliary disease |
| LDH | Non-specific, elevated in many conditions | Liver, cardiac, or hemolytic disorders |
Proteins are complex macromolecules composed of amino acids that perform diverse biological functions. Understanding their structure-function relationships is crucial for medical applications and biochemistry.
Levels of Protein Structure
Primary Structure
- Linear sequence of amino acids connected by peptide bonds
- Determines all higher levels of organization
- Coded by DNA sequence
Secondary Structure
- Local folding patterns stabilized by hydrogen bonds
- Alpha helix: Right-handed spiral structure
- Beta sheet: Extended polypeptide chains arranged side by side
- Beta turn: Connects different secondary structural elements
Tertiary Structure
- Three-dimensional folding of entire polypeptide chain
- Stabilized by:
- Hydrogen bonds
- Disulfide bridges
- Van der Waals forces
- Electrostatic interactions
- Hydrophobic interactions
Quaternary Structure
- Assembly of multiple polypeptide subunits
- Present only in proteins with more than one polypeptide chain
- Examples: Hemoglobin (4 subunits), antibodies
Protein Classification
Based on Structure
-
Fibrous Proteins
- Elongated, insoluble
- Structural functions
- Examples: Collagen, keratin, elastin
-
Globular Proteins
- Compact, soluble
- Functional proteins
- Examples: Enzymes, antibodies, hormones
Based on Composition
-
Simple Proteins
- Composed only of amino acids
- Examples: Albumin, globulins
-
Conjugated Proteins
- Contain non-protein prosthetic groups
- Glycoproteins: Contain carbohydrates
- Lipoproteins: Contain lipids
- Nucleoproteins: Contain nucleic acids
- Phosphoproteins: Contain phosphate groups
- Metalloproteins: Contain metal ions
Regulation of PTH secretion
Secretion of parathyroid hormone is controlled chiefly by serum [Ca2+] through negative feedback. Calcium-sensing receptors located on parathyroid cells are activated when [Ca2+] is low.
Hypomagnesemia inhibits PTH secretion and also causes resistance to PTH, leading to a form of hypoparathyroidism that is reversible.
Hypermagnesemia also results in inhibition of PTH secretion.
Stimulators of PTH includes decreased serum [Ca2+], mild decreases in serum [Mg2+], and an increase in serum phosphate.
Inhibitors include increased serum [Ca2+], severe decreases in serum [Mg2+], which also produces symptoms of hypoparathyroidism (such as hypocalcemia), and calcitriol.
Step 1. Acyl-CoA Dehydrogenase catalyzes oxidation of the fatty acid moiety of acyl-CoA, to produce a double bond between carbon atoms 2 and 3.
There are different Acyl-CoA Dehydrogenases for short (4-6 C), medium (6-10 C), long and very long (12-18 C) chain fatty acids. Very Long Chain Acyl-CoA Dehydrogenase is bound to the inner mitochondrial membrane. The others are soluble enzymes located in the mitochondrial matrix.
FAD is the prosthetic group that functions as electron acceptor for Acyl-CoA Dehydrogenase.
A glutamate side-chain carboxyl extracts a proton from the a-carbon of the substrate, facilitating transfer of 2 e- with H+ (a hydride) from the b position to FAD. The reduced FAD accepts a second H+, yielding FADH2
The carbonyl oxygen of the thioester substrate is hydrogen bonded to the 2'-OH of the ribityl moiety of FAD, giving this part of FAD a role in positioning the substrate and increasing acidity of the substrate a-proton
The reactive glutamate and FAD are on opposite sides of the substrate at the active site. Thus the reaction is stereospecific, yielding a trans double bond in enoyl-CoA.
FADH2 of Acyl CoA Dehydrogenase is reoxidized by transfer of 2 electrons to an Electron Transfer Flavoprotein (ETF), which in turn passes the electrons to coenzyme Q of the respiratory chain.
Step 2. Enoyl-CoA Hydratase catalyzes stereospecific hydration of the trans double bond produced in the 1st step of the pathway, yielding L-hydroxyacyl-Coenzyme A
Step 3. Hydroxyacyl-CoA Dehydrogenase catalyzes oxidation of the hydroxyl in the b position (C3) to a ketone. NAD+ is the electron acceptor.
Step 4. b-Ketothiolase (b-Ketoacyl-CoA Thiolase) catalyzes thiolytic cleavage.
A cysteine S attacks the b-keto C. Acetyl-CoA is released, leaving the fatty acyl moiety in thioester linkage to the cysteine thiol. The thiol of HSCoA displaces the cysteine thiol, yielding fatty acyl-CoA (2 C shorter).
A membrane-bound trifunctional protein complex with two subunit types expresses the enzyme activities for steps 2-4 of the b-oxidation pathway for long chain fatty acids. Equivalent enzymes for shorter chain fatty acids are soluble proteins of the mitochondrial matrix.
Summary of one round of the b-oxidation pathway:
fatty acyl-CoA + FAD + NAD+ + HS-CoA →
fatty acyl-CoA (2 C shorter) + FADH2 + NADH + H+ + acetyl-CoA
The b-oxidation pathway is cyclic. The product, 2 carbons shorter, is the input to another round of the pathway. If, as is usually the case, the fatty acid contains an even number of C atoms, in the final reaction cycle butyryl-CoA is converted to 2 copies of acetyl-CoA
ATP production:
- FADH2 of Acyl CoA Dehydrogenase is reoxidized by transfer of 2 e- via ETF to coenzyme Q of the respiratory chain. H+ ejection from the mitochondrial matrix that accompanies transfer of 2 e- from CoQ to oxygen, leads via chemiosmotic coupling to production of approximately 1.5 ATP. (Approx. 4 H+ enter the mitochondrial matrix per ATP synthesized.)
- NADH is reoxidized by transfer of 2 e- to the respiratory chain complex I. Transfer of 2 e- from complex I to oxygen yields approximately 2.5 ATP.
- Acetyl-CoA can enter Krebs cycle, where the acetate is oxidized to CO2, yielding additional NADH, FADH2, and ATP.
- Fatty acid oxidation is a major source of cellular ATP
b-Oxidation of very long chain fatty acids also occurs within peroxisomes
FAD is electron acceptor for peroxisomal Acyl-CoA Oxidase, which catalyzes the first oxidative step of the pathway. The resulting FADH2 is reoxidized in the peroxisome producing hydrogen peroxide FADH2 + O2 à FAD + H2O2
The peroxisomal enzyme Catalase degrades H2O2 by the reaction:
2 H2O2 → 2 H2O + O2
These reactions produce no ATP
Once fatty acids are reduced in length within the peroxisomes they may shift to the mitochondria to be catabolized all the way to CO2. Carnitine is also involved in transfer of fatty acids into and out of peroxisomes
By rearranging the above equation we arrive at the Henderson-Hasselbalch equation:
pH = pKa + log[A-]/[HA]
It should be obvious now that the pH of a solution of any acid (for which the equilibrium constant is known, and there are numerous tables with this information) can be calculated knowing the concentration of the acid, HA, and its conjugate base [A-].
At the point of the dissociation where the concentration of the conjugate base [A-] = to that of the acid [HA]:
pH = pKa + log[1]
The log of 1 = 0. Thus, at the mid-point of a titration of a weak acid:
pKa = pH
In other words, the term pKa is that pH at which an equivalent distribution of acid and conjugate base (or base and conjugate acid) exists in solution.